tiprankstipranks
Trending News
More News >
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
US Market

Adaptive Biotechnologies (ADPT) Income Statement

Compare
1,008 Followers

Adaptive Biotechnologies Income Statement

Last quarter (Q3 2025), Adaptive Biotechnologies's total revenue was $93.97M, an increase of 102.38% from the same quarter last year. In Q3, Adaptive Biotechnologies's net income was $9.55M. See Adaptive Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 178.96M$ 170.28M$ 185.31M$ 154.34M$ 98.38M
Gross Profit
$ 106.88M$ 94.72M$ 127.40M$ 105.04M$ 75.85M
Operating Expenses
$ 269.43M$ 321.76M$ 327.58M$ 314.01M$ 228.67M
Depreciation and Amortization
$ 19.26M$ 22.23M$ 20.92M$ 13.95M$ 8.47M
EBITDA
$ -128.76M$ -189.27M$ -175.21M$ -193.34M$ -144.34M
Operating Income
$ -162.55M$ -227.03M$ -200.19M$ -208.97M$ -152.82M
Other Income/Expenses
$ 2.95M$ 1.73M$ -182.00K$ 1.67M$ 6.59M
Pretax Income
$ -159.59M$ -225.30M$ -200.37M$ -207.30M$ -146.23M
Net Income
$ -159.49M$ -225.25M$ -200.19M$ -207.28M$ -146.23M
Per Share Metrics
Basic EPS
$ -1.08$ -1.56$ -1.00$ -1.46$ -1.06
Diluted EPS
$ -1.08$ -1.56$ -1.00$ -1.46$ -1.06
Weighted Average Shares Outstanding
147.10M 144.38M 142.52M 140.35M 131.22M
Weighted Average Shares Outstanding (Diluted)
147.10M 144.38M 142.52M 140.35M 131.22M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History